{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:55:42Z","timestamp":1782532542989,"version":"3.54.5"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thoracic.theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Surgery Clinics"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.thorsurg.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,6,14]],"date-time":"2015-06-14T10:13:26Z","timestamp":1434276806000},"page":"309-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Coagulopathy and Anticoagulation During Thoracic Surgery"],"prefix":"10.1016","volume":"25","author":[{"given":"Mathew","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Robert","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.thorsurg.2015.04.005_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccl.2007.12.012","article-title":"Perioperative management of oral anticoagulation","volume":"26","author":"O'Donnell","year":"2008","journal-title":"Cardiol Clin"},{"issue":"4","key":"10.1016\/j.thorsurg.2015.04.005_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1078-5884(97)80079-2","article-title":"Changes in platelet count, coagulation and fibrinogen associated with elective repair of asymptomatic abdominal aortic aneurysm and aortic reconstruction for occlusive disease","volume":"13","author":"Bradbury","year":"1997","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"10.1016\/j.thorsurg.2015.04.005_bib3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.160.6.761","article-title":"Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.thorsurg.2015.04.005_bib4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","article-title":"Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study","volume":"162","author":"Heit","year":"2002","journal-title":"Arch Intern Med"},{"issue":"21","key":"10.1016\/j.thorsurg.2015.04.005_bib5","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199705223362107","article-title":"Management of anticoagulation before and after elective surgery","volume":"336","author":"Kearon","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"2 Suppl","key":"10.1016\/j.thorsurg.2015.04.005_bib6","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.thorsurg.2015.04.005_bib7","first-page":"157","article-title":"Practice of bridging anticoagulation: guideline adherence and risk factors for bleeding","volume":"72","author":"Eijgenraam","year":"2014","journal-title":"Neth J Med"},{"issue":"1","key":"10.1016\/j.thorsurg.2015.04.005_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1160\/TH11-12-0827","article-title":"The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER)","volume":"108","author":"Omran","year":"2012","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.thorsurg.2015.04.005_bib9","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1378\/chest.13-0459","article-title":"Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery: a systematic review of clinical practice guidelines","volume":"144","author":"Darvish-Kazem","year":"2013","journal-title":"Chest"},{"issue":"23","key":"10.1016\/j.thorsurg.2015.04.005_bib10","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1161\/CIR.0000000000000031","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Nishimura","year":"2014","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.thorsurg.2015.04.005_bib11","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.jacc.2014.07.944","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Fleisher","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.thorsurg.2015.04.005_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0025-6196(11)60891-4","article-title":"Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation","volume":"83","author":"Wysokinski","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.thorsurg.2015.04.005_bib13","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/archinte.164.12.1319","article-title":"Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen","volume":"164","author":"Douketis","year":"2004","journal-title":"Arch Intern Med"},{"issue":"27","key":"10.1016\/j.thorsurg.2015.04.005_bib14","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1093\/eurheartj\/eht134","article-title":"EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary","volume":"34","author":"Heidbuchel","year":"2013","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.thorsurg.2015.04.005_bib15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.111.029017","article-title":"Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects","volume":"124","author":"Eerenberg","year":"2011","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.thorsurg.2015.04.005_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11936-014-0326-1","article-title":"The role of novel anticoagulants in the management of venous thromboembolic disease","volume":"16","author":"Kitslaar","year":"2014","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"8882","key":"10.1016\/j.thorsurg.2015.04.005_bib17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group","volume":"342","year":"1993","journal-title":"Lancet"},{"issue":"3 Suppl","key":"10.1016\/j.thorsurg.2015.04.005_bib18","doi-asserted-by":"crossref","first-page":"457S","DOI":"10.1378\/chest.126.3_suppl.457S","article-title":"Antithrombotic therapy in valvular heart disease\u2013native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Salem","year":"2004","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.thorsurg.2015.04.005_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.thromres.2014.06.003","article-title":"Specific risk scores for specific purposes: use CHA2DS2-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation","volume":"134","author":"Dzeshka","year":"2014","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.thorsurg.2015.04.005_bib20","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1538-7836.2010.03781.x","article-title":"Risk of stroke after surgery in patients with and without chronic atrial fibrillation","volume":"8","author":"Kaatz","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"13","key":"10.1016\/j.thorsurg.2015.04.005_bib21","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.thorsurg.2015.04.005_bib22","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/archinte.158.12.1316","article-title":"Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials","volume":"158","year":"1998","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.thorsurg.2015.04.005_bib23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-131-9-199911020-00010","article-title":"Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"issue":"3 Suppl","key":"10.1016\/j.thorsurg.2015.04.005_bib24","doi-asserted-by":"crossref","first-page":"429S","DOI":"10.1378\/chest.126.3_suppl.429S","article-title":"Antithrombotic therapy in atrial fibrillation: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Singer","year":"2004","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.thorsurg.2015.04.005_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ahj.2014.03.015","article-title":"Which risk score best predicts perioperative outcomes in nonvalvular atrial fibrillation patients undergoing noncardiac surgery?","volume":"168","author":"van Diepen","year":"2014","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.thorsurg.2015.04.005_bib26","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","article-title":"Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)","volume":"10","author":"Tosetto","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"10.1016\/j.thorsurg.2015.04.005_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJM200107193450302","article-title":"Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators","volume":"345","author":"Agnelli","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.thorsurg.2015.04.005_bib28","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/annonc\/mds058","article-title":"Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients","volume":"23","author":"Tafur","year":"2012","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.thorsurg.2015.04.005_bib29","first-page":"823","article-title":"Recurrence of venous thromboembolism","volume":"73","author":"Coon","year":"1973","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.thorsurg.2015.04.005_bib30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archinte.163.8.901","article-title":"Perioperative management of patients receiving oral anticoagulants: a systematic review","volume":"163","author":"Dunn","year":"2003","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.thorsurg.2015.04.005_bib31","doi-asserted-by":"crossref","first-page":"JC13","DOI":"10.7326\/0003-4819-158-6-201303190-02013","article-title":"ACP Journal Club. Scores poorly predict major bleeding (c-statistics <\/= 0.61) during oral anticoagulant therapy","volume":"158","author":"White","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.thorsurg.2015.04.005_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.thromres.2014.05.002","article-title":"Misinterpretation of the HAS-BLED bleeding score by end-users","volume":"134","author":"Gulec","year":"2014","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.thorsurg.2015.04.005_bib33","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.thorsurg.2015.04.005_bib34","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2141.2007.06968.x","article-title":"Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology","volume":"140","author":"Chee","year":"2008","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.thorsurg.2015.04.005_bib35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/ATVBAHA.109.199406","article-title":"Periprocedural anticoagulation management of patients with venous thromboembolism","volume":"30","author":"McBane","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"22","key":"10.1016\/j.thorsurg.2015.04.005_bib36","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/CIRCULATIONAHA.108.823211","article-title":"Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study","volume":"119","author":"Pengo","year":"2009","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.thorsurg.2015.04.005_bib37","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1200\/JCO.2005.03.133","article-title":"Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism","volume":"23","author":"Lee","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"9211","key":"10.1016\/j.thorsurg.2015.04.005_bib38","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(00)02085-7","article-title":"Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial","volume":"355","author":"Berge","year":"2000","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.thorsurg.2015.04.005_bib39","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/01.STR.0000035735.49388.4A","article-title":"Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials","volume":"33","author":"Hart","year":"2002","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.thorsurg.2015.04.005_bib40","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1161\/hs1001.097093","article-title":"Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial","volume":"32","author":"Saxena","year":"2001","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.thorsurg.2015.04.005_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-122-1-199501010-00006","article-title":"Temporary discontinuation of warfarin therapy: changes in the international normalized ratio","volume":"122","author":"White","year":"1995","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.thorsurg.2015.04.005_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-135-6-200109180-00008","article-title":"Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin","volume":"135","author":"Hylek","year":"2001","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.thorsurg.2015.04.005_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cger.2005.09.008","article-title":"Perioperative management of oral anticoagulation","volume":"22","author":"O'Donnell","year":"2006","journal-title":"Clin Geriatr Med"},{"issue":"12","key":"10.1016\/j.thorsurg.2015.04.005_bib44","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.acvd.2011.09.001","article-title":"Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the working group on perioperative haemostasis and the French Study Group on Thrombosis and Haemostasis","volume":"104","author":"Sie","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.thorsurg.2015.04.005_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-146-3-200702060-00007","article-title":"Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin","volume":"146","author":"O'Donnell","year":"2007","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.thorsurg.2015.04.005_bib46","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1538-7836.2007.02729.x","article-title":"Bridging therapy in patients on long-term oral anticoagulants who require surgery: the prospective peri-operative enoxaparin cohort trial (PROSPECT)","volume":"5","author":"Dunn","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.thorsurg.2015.04.005_bib47","first-page":"2128","article-title":"Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents","volume":"183","author":"Eberli","year":"2010","journal-title":"J\u00a0Urol"},{"issue":"9","key":"10.1016\/j.thorsurg.2015.04.005_bib48","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.amjcard.2009.06.038","article-title":"Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents","volume":"104","author":"van Kuijk","year":"2009","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.thorsurg.2015.04.005_bib49","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.thorsurg.2015.04.005_bib50","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.thorsurg.2015.04.005_bib51","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/ccd.22744","article-title":"Frequency and risk of noncardiac surgery after drug-eluting stent implantation","volume":"77","author":"Gandhi","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.thorsurg.2015.04.005_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HPC.0b013e31826c53cd","article-title":"Recommendations for management of antiplatelet therapy in patients undergoing elective noncardiac surgery after coronary stent implantation","volume":"11","author":"Huang","year":"2012","journal-title":"Crit Pathw Cardiol"},{"issue":"11","key":"10.1016\/j.thorsurg.2015.04.005_bib53","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.112.102715","article-title":"Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study","volume":"126","author":"Wijeysundera","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.thorsurg.2015.04.005_bib54","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.amjcard.2006.12.025","article-title":"Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries","volume":"99","author":"Artang","year":"2007","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.thorsurg.2015.04.005_bib55","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","volume":"115","author":"Grines","year":"2007","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.thorsurg.2015.04.005_bib56","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2010.07.016","article-title":"Stent thrombosis","volume":"56","author":"Holmes","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.thorsurg.2015.04.005_bib57","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcin.2009.11.017","article-title":"Perioperative management of patients with drug-eluting stents","volume":"3","author":"Abualsaud","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.thorsurg.2015.04.005_bib58","first-page":"1373","article-title":"Preclinical restenosis models and drug-eluting stents: still important, still much to learn","volume":"44","author":"Schwartz","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.thorsurg.2015.04.005_bib59","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/CIRCULATIONAHA.105.609057","article-title":"Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents","volume":"116","author":"Awata","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.thorsurg.2015.04.005_bib60","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.amjcard.2014.08.023","article-title":"Non-cardiac surgery after percutaneous coronary intervention","volume":"114","author":"Sanon","year":"2014","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.thorsurg.2015.04.005_bib61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans","volume":"129","author":"Otsuka","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.thorsurg.2015.04.005_bib62","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/bja\/ael228","article-title":"Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force","volume":"97","author":"Albaladejo","year":"2006","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.thorsurg.2015.04.005_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCINTERVENTIONS.109.934703","article-title":"Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery","volume":"3","author":"Cruden","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.thorsurg.2015.04.005_bib64","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.anes.0000265180.05867.4a","article-title":"Coronary artery stent placement immediately before noncardiac surgery: a potential risk?","volume":"106","author":"Schouten","year":"2007","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.thorsurg.2015.04.005_bib65","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjcard.2004.11.029","article-title":"Risks of noncardiac surgery after coronary stenting","volume":"95","author":"Reddy","year":"2005","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.thorsurg.2015.04.005_bib66","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/bja\/aeq003","article-title":"To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial","volume":"104","author":"Oscarsson","year":"2010","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.thorsurg.2015.04.005_bib67","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2796.2005.01477.x","article-title":"Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis","volume":"257","author":"Burger","year":"2005","journal-title":"J\u00a0Intern Med"},{"issue":"4","key":"10.1016\/j.thorsurg.2015.04.005_bib68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ccd.23172","article-title":"Bridging with glycoprotein IIb\/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents","volume":"79","author":"Ben Morrison","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.thorsurg.2015.04.005_bib69","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4244\/EIJV9I2A35","article-title":"Outcomes of a preoperative \u201c bridging\u201d strategy with glycoprotein IIb\/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration","volume":"9","author":"Alshawabkeh","year":"2013","journal-title":"EuroIntervention"},{"issue":"2 Suppl","key":"10.1016\/j.thorsurg.2015.04.005_bib70","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and\u00a0prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.thorsurg.2015.04.005_bib71","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1365-2141.2006.06226.x","article-title":"Guidelines on use of\u00a0vena cava filters","volume":"134","author":"Baglin","year":"2006","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.thorsurg.2015.04.005_bib72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.blre.2013.07.001","article-title":"Vena cava filters for management of venous thromboembolism: a clinical review","volume":"27","author":"Rajasekhar","year":"2013","journal-title":"Blood Rev"},{"issue":"7","key":"10.1016\/j.thorsurg.2015.04.005_bib73","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","article-title":"A\u00a0clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group","volume":"338","author":"Decousus","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.thorsurg.2015.04.005_bib74","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood.V95.12.3669","article-title":"Vena caval filters: a comprehensive review","volume":"95","author":"Streiff","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thorsurg.2015.04.005_bib75","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00776-009-1368-1","article-title":"Assessment of thrombotic risk factors predisposing to thromboembolic complications in prosthetic orthopedic surgery","volume":"14","author":"Szucs","year":"2009","journal-title":"J\u00a0Orthop Sci"},{"issue":"8","key":"10.1016\/j.thorsurg.2015.04.005_bib76","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.10234","article-title":"The risk of\u00a0recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies","volume":"92","author":"Marchiori","year":"2007","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.thorsurg.2015.04.005_bib77","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s11926-014-0426-7","article-title":"Perioperative management of antiphospholipid antibody-positive patients","volume":"16","author":"Saunders","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.thorsurg.2015.04.005_bib78","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1011237019082","article-title":"Anaphylactoid reactions to vitamin K","volume":"11","author":"Fiore","year":"2001","journal-title":"J\u00a0Thromb Thrombolysis"}],"container-title":["Thoracic Surgery Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412715000249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412715000249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T12:15:04Z","timestamp":1691756104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547412715000249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1547412715000249"],"URL":"https:\/\/doi.org\/10.1016\/j.thorsurg.2015.04.005","relation":{},"ISSN":["1547-4127"],"issn-type":[{"value":"1547-4127","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulopathy and Anticoagulation During Thoracic Surgery","name":"articletitle","label":"Article Title"},{"value":"Thoracic Surgery Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thorsurg.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}